FTC sues major pharmacy reward professionals more than insulin costs The agency brought action in opposition to Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing price of lifetime-saving insulin prescription drugs. Listen to the report ten min This audio is automobile-produced. https://daveshotchickencalories31739.mybuzzblog.com/10239059/healthcare-news-an-overview